Vanguard Group
DXTR

Vanguard Group’s Dextera Surgical Inc. DXTR Stock Holding History

Vanguard Group’s Portfolio DXTR Stock Details DXTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-314,091
Closed -$87K – 4102
2017
Q3 		$87K Buy
314,091
+157,979
+101% +$45.5K ﹤0.01% 4000
2017
Q2 		$47K Sell
156,112
-199,025
-56% -$101K ﹤0.01% 4030
2017
Q1 		$377K Buy
355,137
+143,687
+68% +$185K ﹤0.01% 3804
2016
Q4 		$203K Buy
211,450
+800
+0.4% +$1.21K ﹤0.01% 3891
2016
Q3 		$398K Sell
210,650
-4,344
-2% -$9.24K ﹤0.01% 3797
2016
Q2 		$387K Buy
+214,994
New +$440K ﹤0.01% 3830

Other funds holding DXTR

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

Vanguard Group's DXTR Position: Q4 2017 in Review

Vanguard Group sold out of Dextera Surgical Inc. (DXTR) in Q4 2017, closing a stake of 314,091 shares — an estimated $87K sold.

Vanguard Group first reported a position in DXTR in Q2 2016 and held it in 6 quarters. The position peaked at $398K in Q3 2016. 3 funds tracked by Wall St. Rank hold DXTR as of Q4 2017.

  • Vanguard Group reported no remaining Dextera Surgical Inc. position as of Q4 2017 after selling out during the quarter.
  • Vanguard Group sold 314,091 Dextera Surgical Inc. shares in Q4 2017, an estimated $87K.
  • Vanguard Group first reported a position in Dextera Surgical Inc. in Q2 2016 and held it in 6 quarters.
  • Vanguard Group's Dextera Surgical Inc. position peaked at $398K in Q3 2016.
  • 3 funds tracked by Wall St. Rank held Dextera Surgical Inc. as of Q4 2017.

Based on Vanguard Group's 13F filing for Q4 2017, filed 14 Feb 2018.